Metagenomic next-generation sequencing identifies native valve Aspergillus fumigatus endocarditis with cerebral

Weibing Wu1, Jingjing Xu2, Jianling Ruan3

  • 1Department of Critical Care Medicine, Qingyuan People's Hospital, Lishui, China.

Insights

This case report details a rare Aspergillus fumigatus endocarditis with brain infection. Metagenomic sequencing rapidly diagnosed this fatal condition, emphasizing advanced diagnostics for better outcomes.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Medical Diagnostics

Background:

  • Aspergillus endocarditis is a rare, often fatal infection, especially in immunocompromised individuals.
  • Native valve endocarditis caused by Aspergillus fumigatus presents diagnostic challenges.
  • Intracranial complications of fungal endocarditis are uncommon and difficult to diagnose.

Observation:

  • A 74-year-old male presented with symptoms suggestive of endocarditis and intracranial infection.
  • Blood cultures were negative, complicating the diagnostic process.
  • The patient had a native valve infection with Aspergillus fumigatus.

Findings:

  • Metagenomic next-generation sequencing (mNGS) successfully identified Aspergillus fumigatus.
  • This is the first documented case of Aspergillus fumigatus endocarditis with cerebral involvement diagnosed via mNGS.
  • The diagnosis was confirmed despite an atypical clinical presentation.

Implications:

  • mNGS offers a rapid and effective diagnostic tool for rare and severe fungal infections.
  • Early and accurate diagnosis is crucial for managing Aspergillus endocarditis and its neurological complications.
  • This case underscores the importance of considering advanced sequencing techniques in complex infectious disease scenarios.